Pharmafile Logo
Pharmafocus logo
Advanced Search

Public Relations

Showing 6 posts of 6 posts found.

Power of partnership: Turning shared purpose into improved shared decision-making in rare disease

September 5, 2026 Internal Communication Campaigns, Market Access Consultancy, Medical Communications, Medical Communications Training, Patient Advocacy Rare Diseases, ZPB Associates

In February 2026, PMGroup Worldwide Ltd and Visions4Health launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise innovative collaborations …
Feature

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026 Patient Awareness Programmes Bowel Cancer Awareness Month, Stage4You, mental health

Stage4You, a campaign funded and developed by Takeda UK and supported by Bowel Cancer UK, is encouraging patients with stage …
Feature

Kidney Research UK backs digital innovation to support 15 million patients with long-term conditions

April 22, 2025 Medical Education, Patient Awareness Programmes, Public Relations Cognitant Group, Kidney Research UK, Nephrology, chronic kidney disease (CKD)

Kidney Research UK has announced an ambitious investment in the patient engagement platform Healthinote, developed by Cognitant Group, in a …
News

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

January 23, 2025 Medical Communications, Public Relations Heart of Pharma, Paris, pharmapack

Six start-ups bestowed with new ‘heart of pharma’ commendation in recognition of innovations advancing drug delivery and packaging 22 January …
News
Press release

Pharma services boom in China as CPHI & PMEC China posts record attendance

August 8, 2024 Conferencing, Events & Incentives, Public Relations, Sales and Marketing CPHI China, PMEC China, pharma

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes a staggering 93,000 attendees 08 August, 2024, …
News
Press release

FDA release statement exercising caution around dosing errors associated with compounded injectable semaglutide products

July 31, 2024 Media Relations, Medical Communications, Pharmacovigilance, US Healthcare & Trade Press FDA, Gastrointestinal tract, compunded injectable, dosage, hospitalisation, pharmaceutical, warning

This week, the US Food and Drug Administration (FDA) and have issued warnings regarding dosing errors associated with compounded injectable …
News
The Gateway to Local Adoption Series

Latest content

NIHR chief scientific adviser visits Huddersfield health innovation campus

September 25, 2026

One in three UK women with migraine say symptoms taken less seriously

September 24, 2026

Report highlights scope to expand day surgery

September 23, 2026

Sygnature formalises drug discovery collaboration with X-Chem

September 22, 2026

Codis appoints Steven Facer as chief commercial officer

September 21, 2026